Low Perception of Obesity as a Pathological Condition Among Italian Cardiologists

Article Cardiac & Cardiovascular Systems

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox

Jawad H. Butt et al.

Summary: This study found that newer anthropometric measures such as waist-to-height ratio, rather than body mass index (BMI), accurately predicted the risk of heart failure hospitalization and cardiovascular death in patients with heart failure. The study also showed a positive correlation between waist-to-height ratio and higher levels of obesity, as well as increased risk of heart failure hospitalization.

EUROPEAN HEART JOURNAL (2023)

Add to Collection

Article Multidisciplinary Sciences

Contribution of obesity and cardiometabolic risk factors in developing cardiovascular disease: a population-based cohort study

Mahmood Bakhtiyari et al.

Summary: This study found that in men, systolic blood pressure plays a crucial mediating role in general and central obesity, accounting for more than 60% of the risk. However, in women, controlling metabolic risk factors does not efficiently contribute to decreasing cardiovascular diseases as effectively as in men.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Medicine, General & Internal

Once-Weekly Semaglutide in Adolescents with Obesity

Daniel Weghuber et al.

Summary: This double-blind, randomized, placebo-controlled trial found that once-weekly treatment with a 2.4-mg dose of semaglutide plus lifestyle intervention resulted in a greater reduction in BMI than lifestyle intervention alone among adolescents with obesity.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John P. H. Wilding et al.

Summary: The study demonstrates that for individuals with obesity, once-weekly use of 2.4 mg semaglutide in combination with lifestyle intervention can lead to sustained and clinically relevant weight loss, with significant improvements in cardiometabolic risk factors and physical functioning reported by participants.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study

Maria Ruiz-Castell et al.

Summary: The study found a significant association between visceral adiposity and cardiometabolic diseases, with an increased risk of hypertension, prediabetes/diabetes, hypercholesterolemia, and hypertriglyceridemia as visceral adipose tissue increases. Additionally, women had higher odds for all outcomes compared to men except for hypertension, suggesting a gender difference in the impact of visceral adiposity on cardiometabolic health. Future research should explore the effects of changes in visceral adipose tissue on cardiometabolic health and the use of anthropometrically predicted VAT as a reliable outcome measure in the absence of biomedical imaging.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)

Frank L. J. Visseren et al.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Review Endocrinology & Metabolism

Obesity: Epidemiology, Pathophysiology, and Therapeutics

Xihua Lin et al.

Summary: Obesity is a complex multifactorial disease with negative health effects, mainly caused by an energy imbalance. Treatment strategies should focus on biological mechanisms and reducing BMI.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Review Respiratory System